Respiratory Medicine
Volume 104, Issue 5 , Pages 712-716 , May 2010

Association of COPD with carotid wall intima-media thickness in vascular surgery patients

  • Yvette R.B.M. van Gestel

      Affiliations

    • Department of Anesthesiology, Erasmus Medical Center, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
  • ,
  • Willem-Jan Flu

      Affiliations

    • Department of Vascular Surgery, Erasmus Medical Center, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
  • ,
  • Jan-Peter van Kuijk

      Affiliations

    • Department of Vascular Surgery, Erasmus Medical Center, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
  • ,
  • Sanne E. Hoeks

      Affiliations

    • Department of Anesthesiology, Erasmus Medical Center, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
  • ,
  • Jeroen J. Bax

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
  • ,
  • Don D. Sin

      Affiliations

    • Department of Medicine, University of British Columbia & The James Hogg iCAPTURE Center, St. Paul's Hospital, 1081 Burrard St, Vancouver, BC, Canada
  • ,
  • Don Poldermans

      Affiliations

    • Department of Vascular Surgery, Erasmus Medical Center, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Vascular Surgery, Erasmus Medical Center Rotterdam, Room H-805, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. Tel.: +31 10 7034613; fax: +31 10 7034957.

Received 1 October 2009 ,Accepted 30 October 2009.

References 

  1. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005 Jun;127:1952–1959
  2. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2:8–11
  3. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003 Mar 25;107:1514–1519
  4. de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004 Jun 15;109:III33–III38
  5. Iwamoto H, Yokoyama A, Kitahara Y, Ishikawa N, Haruta Y, Yamane K, et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med. 2009 Jan 1;179:35–40
  6. Schunemann HJ, Dorn J, Grant BJ, Winkelstein W, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest. 2000 Sep;118:656–664
  7. Zureik M, Kauffmann F, Touboul PJ, Courbon D, Ducimetiere P. Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med. 2001 Jul 9;161:1669–1676
  8. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke. 1999 Apr;30:841–850
  9. Engstrom G, Hedblad B, Valind S, Janzon L. Asymptomatic leg and carotid atherosclerosis in smokers is related to degree of ventilatory capacity: longitudinal and cross-sectional results from ‘Men born in 1914’, Sweden. Atherosclerosis. 2001 Mar;155:237–243
  10. Flu WJ, van Kuijk JP, Hoeks SE, Kuiper R, Schouten O, Goei D, et al. Intima media thickness of the common carotid artery in vascular surgery patients: a predictor of postoperative cardiovascular events. Am Heart J. 2009 Aug;158:202–208
  11. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007 Sep 15;176:532–555
  12. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovascular Dis. 2007;23:75–80
  13. Schroeder EB, Welch VL, Evans GW, Heiss G. Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis. 2005 Jun;180:367–373
  14. Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke. 2007 Jun;38:1774–1779
  15. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994 Nov 16;272:1497–1505
  16. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007 May;62:411–415

PII: S0954-6111(09)00363-1

doi: 10.1016/j.rmed.2009.10.027

Respiratory Medicine
Volume 104, Issue 5 , Pages 712-716 , May 2010